China-based Kexing Biopharm Co., Ltd. (SHA: 688136) and Hangzhou Bio-Sincerity Pharmaceutical Technology Co., Ltd. (SHE: 301096) have entered into a strategic partnership to collaborate on innovative drug development and overseas commercialization.
Partnership Details
The alliance aims to leverage the strengths of both companies in drug development and commercialization. The partnership will focus on innovative drug development and expanding into overseas markets. Financial terms of the agreement were not disclosed.-Fineline Info & Tech
Leave a Reply